array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Bio-RAD Laboratories, Inc."
["slug"]=>
string(33) "001cd-us-bio-rad-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920"
["description"]=>
string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics"
["address_street"]=>
string(20) "1000 Alfred Nobel Dr"
["address_place"]=>
string(8) "Hercules"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1952-02-08"
["website_domain"]=>
string(11) "bio-rad.com"
["website_url"]=>
string(23) "https://www.bio-rad.com"
["industry_codes"]=>
array(3) {
[0]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
[1]=>
string(33) "Laboratory Analytical Instruments"
[2]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(7900)
["article_count"]=>
int(684)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(92) "Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Crosses Above 50-Day Moving Average of $324.95"
["snippet_en"]=>
string(222) "Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report)’s share price crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $324.95 and traded as high as $334.10."
["url"]=>
string(133) "https://www.defenseworld.net/2024/03/05/bio-rad-laboratories-nysebio-b-stock-price-crosses-above-50-day-moving-average-of-324-95.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/2f4ef90c-1d67-4755-a782-9192e45a5ff3"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2024-03-05"
["categories"]=>
array(1) {
[0]=>
string(12) "Stock Market"
}
}
[1]=>
array(7) {
["title_en"]=>
string(73) "Scope Fluidics (WSE:SCP) - Stock Price, News & Analysis - Simply Wall St"
["snippet_en"]=>
string(155) "Research Scope Fluidics' (WSE:SCP) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more."
["url"]=>
string(72) "https://simplywall.st/stocks/pl/healthcare/wse-scp/scope-fluidics-shares"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6d70ed64-378e-46e9-bb90-37dead2c5896"
["source"]=>
string(13) "simplywall.st"
["publication_date"]=>
string(10) "2024-02-26"
["categories"]=>
array(5) {
[0]=>
string(15) "Market Movement"
[1]=>
string(12) "Stock Market"
[2]=>
string(24) "Stock Research & Ratings"
[3]=>
string(9) "Valuation"
[4]=>
string(18) "General Investment"
}
}
[2]=>
array(7) {
["title_en"]=>
string(80) "Bio-Rad Laboratories (NYSE:BIO) - Stock Price, News & Analysis - Simply Wall St"
["snippet_en"]=>
string(162) "Research Bio-Rad Laboratories' (NYSE:BIO) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more."
["url"]=>
string(85) "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bio/bio-rad-laboratories"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/8141cc14-f185-4b4b-8269-b0c9b83caef8"
["source"]=>
string(13) "simplywall.st"
["publication_date"]=>
string(10) "2024-01-24"
["categories"]=>
array(5) {
[0]=>
string(12) "Board Change"
[1]=>
string(15) "Market Movement"
[2]=>
string(12) "Stock Market"
[3]=>
string(24) "Stock Research & Ratings"
[4]=>
string(10) "Executives"
}
}
[3]=>
array(7) {
["title_en"]=>
string(84) "Zacks Research Weighs in on Bio-Rad Laboratories, Inc.'s Q1 2025 Earnings (NYSE:BIO)"
["snippet_en"]=>
string(300) "Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Stock analysts at Zacks Research cut their Q1 2025 EPS estimates for Bio-Rad Laboratories in a research note issued to investors on Tuesday, January 16th. Zacks Research analyst R. Anand now forecasts that the medical research company will pos"
["url"]=>
string(89) "https://www.marketbeat.com/instant-alerts/nyse-bio-analyst-earnings-estimates-2024-01-19/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4c2cc902-3ad5-47d1-82b6-b5f42dbe6540"
["source"]=>
string(14) "marketbeat.com"
["publication_date"]=>
string(10) "2024-01-19"
["categories"]=>
array(7) {
[0]=>
string(13) "Credit Rating"
[1]=>
string(17) "Academic Research"
[2]=>
string(12) "Stock Market"
[3]=>
string(5) "R & D"
[4]=>
string(9) "Investors"
[5]=>
string(24) "Quarterly/Annual Figures"
[6]=>
string(24) "Stock Research & Ratings"
}
}
[4]=>
array(7) {
["title_en"]=>
string(74) "Implied Volatility Surging for On Bio-Rad Laboratories (BIO) Stock Options"
["snippet_en"]=>
string(230) "Investors in Bio-Rad Laboratories, Inc. BIO need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 15, 2023 $240.00 Call had some of the highest implied volatility of all equi"
["url"]=>
string(104) "https://www.nasdaq.com/articles/implied-volatility-surging-for-on-bio-rad-laboratories-bio-stock-options"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2023-11-20"
["categories"]=>
array(3) {
[0]=>
string(9) "Investors"
[1]=>
string(15) "Market Movement"
[2]=>
string(12) "Stock Market"
}
}
[5]=>
array(7) {
["title_en"]=>
string(67) "Not Big Tech – 3 S&P 500 Stocks With the Highest Upside Potential"
["snippet_en"]=>
string(152) "The S&P 500 (SPX) just had its best week of 2023, as it gained about 5.9%. Still, there are a few S&P 500 stocks (not the same old big tech stocks) that"
["url"]=>
string(94) "https://news-24.fr/pas-big-tech-3-actions-du-sp-500-avec-le-potentiel-de-hausse-le-plus-eleve/"
["image_url"]=>
NULL
["source"]=>
string(10) "news-24.fr"
["publication_date"]=>
string(10) "2023-11-04"
["categories"]=>
array(1) {
[0]=>
string(12) "Stock Market"
}
}
[6]=>
array(7) {
["title_en"]=>
string(66) "Bio-Rad Laboratories (BIO) Q3 Earnings and Revenues Miss Estimates"
["snippet_en"]=>
string(188) "Bio-Rad (BIO) delivered earnings and revenue surprises of -18.82% and 8.47%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?"
["url"]=>
string(73) "https://finance.yahoo.com/news/bio-rad-laboratories-bio-q3-214015742.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/54218d72-8d2f-496a-b2cb-e093122752ad"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-10-26"
["categories"]=>
array(3) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(12) "Stock Market"
[2]=>
string(31) "Financial Update/Profit Warning"
}
}
[7]=>
array(7) {
["title_en"]=>
string(52) "Bio-Rad Shares Drop After Company Reports 3Q Results"
["snippet_en"]=>
string(160) "By Stephen Nakrosis Shares of Bio-Rad Laboratories were trading lower in the after-hours market following the release of third-quarter financial results that..."
["url"]=>
string(95) "https://www.marketwatch.com/story/bio-rad-shares-drop-after-company-reports-3q-results-0d9c70ab"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/3bebe02f-4333-46c5-bde4-e8e5d9bb24c2"
["source"]=>
string(15) "marketwatch.com"
["publication_date"]=>
string(10) "2023-10-26"
["categories"]=>
array(7) {
[0]=>
string(15) "Market Movement"
[1]=>
string(12) "Stock Market"
[2]=>
string(31) "Financial Update/Profit Warning"
[3]=>
string(24) "Quarterly/Annual Figures"
[4]=>
string(14) "Issuing Shares"
[5]=>
string(24) "Stock Research & Ratings"
[6]=>
string(21) "Financial Performance"
}
}
[8]=>
array(7) {
["title_en"]=>
string(62) "Investors are worried about growing volatility | Investing.com"
["snippet_en"]=>
string(143) "Alexey Kalachev: market overview, including XAU/USD, S&P 500, Dow Jones Industrial Average, Nikkei 225. Latest market analysis on Investing.com"
["url"]=>
string(51) "https://ru.investing.com/analysis/article-200308103"
["image_url"]=>
NULL
["source"]=>
string(13) "investing.com"
["publication_date"]=>
string(10) "2023-10-18"
["categories"]=>
array(12) {
[0]=>
string(15) "Market Movement"
[1]=>
string(12) "Stock Market"
[2]=>
string(16) "Share Repurchase"
[3]=>
string(31) "Financial Update/Profit Warning"
[4]=>
string(24) "Quarterly/Annual Figures"
[5]=>
string(14) "Issuing Shares"
[6]=>
string(11) "Acquisition"
[7]=>
string(24) "Stock Research & Ratings"
[8]=>
string(5) "Debts"
[9]=>
string(18) "General Investment"
[10]=>
string(19) "Investment Requests"
[11]=>
string(25) "Business Model Resilience"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(66)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(51)
}
[2]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(32)
}
[3]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(30)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(26)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(20)
}
[8]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(20)
}
[9]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(19)
}
[11]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(18)
}
[12]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(15)
}
[13]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(14)
}
[14]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[15]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(13)
}
[16]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(10)
}
[17]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(10)
}
[18]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(8)
}
[21]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(5)
}
}
}
001cd-us-bio-rad-laboratories-inc
Bio-RAD Laboratories, Inc.
Location
California
Founded
1952-02-08
Website
https://www.bio-rad.com
Articles
684 Articles
Category
In Vitro and In Vivo Diagnostic Substances
Laboratory Analytical Instruments
Electromedical and Electrotherapeutic Apparatus
Description
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics
Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report)’s share price crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $324.95 and traded as high as $334.10.
Research Scope Fluidics' (WSE:SCP) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
Research Bio-Rad Laboratories' (NYSE:BIO) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Stock analysts at Zacks Research cut their Q1 2025 EPS estimates for Bio-Rad Laboratories in a research note issued to investors on Tuesday, January 16th. Zacks Research analyst R. Anand now forecasts that the medical research company will pos
Investors in Bio-Rad Laboratories, Inc. BIO need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 15, 2023 $240.00 Call had some of the highest implied volatility of all equi
The S&P 500 (SPX) just had its best week of 2023, as it gained about 5.9%. Still, there are a few S&P 500 stocks (not the same old big tech stocks) that
Bio-Rad (BIO) delivered earnings and revenue surprises of -18.82% and 8.47%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
By Stephen Nakrosis Shares of Bio-Rad Laboratories were trading lower in the after-hours market following the release of third-quarter financial results that...
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.